The Food and Drugs Authority is cautioning the public against the use of injectable glutathione and other unapproved products for purposes of skin lightening, bleaching, correction of uneven skin tone and reduction of blemishes.
According to the authority in a communique dated October 4, 2021, there has not been any “clinical evidence on the safety and effectiveness of the products” neither are there “published guidelines for correct dosing and duration of treatment.”
In light of the reason given, they warn that the continuous use of the products pose lots of risks to the consumers of which some are liver, kidney and the nervous system problems and also the risk of suffering serious skin reaction known as “Stevens Johnson Syndrome.”
“Glutathione which also affects the production of the pigment that gives the human skin its colour (melanin), may pose a risk of skin cancer with long term use”, the statement added.
The caution follows promotions on social media on the use of the injectable skin lightening agents which the FDA finds worrying because of concerns that the products may not come from authorized and professional sources.
There is more in the statement below:
